Milestone Scientific (NYSE:MLSS) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSSGet Rating) in a research note issued to investors on Monday morning. The brokerage issued a sell rating on the stock.

Milestone Scientific Stock Down 8.5 %

Shares of MLSS stock opened at $0.57 on Monday. The business has a 50 day moving average of $0.72 and a two-hundred day moving average of $0.89. The company has a market cap of $39.56 million, a P/E ratio of -4.78 and a beta of 1.33. Milestone Scientific has a 52 week low of $0.55 and a 52 week high of $2.67.

About Milestone Scientific

(Get Rating)

Milestone Scientific Inc designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic.

See Also

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.